Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in PEPG — PepGen Inc.

CIK 1423053 MIAMI, FL
Back to PEPG Full portfolio

Position in PEPG

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$1,185,085
+$817,064 QoQ
Shares Held
658,381
+216.6% QoQ
Ownership
0.951%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 72 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PEPG Over Time

Shares Held

Position Value (USD)

Derivatives in PEPG

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$23,580
PutShares
13,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. PEPG ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in PEPG

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,185,085 658,381
2026-06-30 $23,580 13,100
2026-03-31 $84,606 47,800
2026-03-31 $368,021 207,922
2026-03-31 $191,160 108,000
2025-12-31 $1,743,306 267,789
2025-12-31 $120,435 18,500
2025-09-30 $98,868 21,400
2025-09-30 $1,373,331 297,258
2025-09-30 $389,928 84,400
2025-03-31 $113,524 80,800
2025-03-31 $127 91
2025-03-31 $27,538 19,600
2024-12-31 $443 117
2024-12-31 $56,850 15,000
2022-09-30 $3,121,259 343,751
2022-06-30 $2,914,861 293,541